R&D Archives - GalChimia

Advances in the development of antileishmanial treatments

May 28, 2019 · R&D

Our team in Madrid was involved in the development of antileishmanial compounds. This research was made in collaboration with GSK and Dundee University.

Results of the Nanofacturing project

April 16, 2019 · Made in GalChimia, R&D

GalChimia thanks all the partners of the Nanofacturing project for the involvement and teamwork that have been key to obtaining the results.

Droughtdrugs Project, discovery of agrochemicals to improve drought tolerance in crop plants

February 26, 2019 · R&D

The main objective of the Droughtdrugs Project is to develop a new generation of compounds that can activate drought tolerance in crop plants.

GalChimia, Oncostellae y AMSlab presentan el proyecto IO4COLON

February 25, 2019 · R&D

IO4COLON es una iniciativa de investigación liderada por GalChimia, Oncostellae y AMSlab para el descubrimiento de nuevos fármacos contra el cáncer de colon

GalChimia is happy to be part of a collaborative effort to boost EU Synthetic Biology competitiveness

January 17, 2019 · R&D

An 8 million Euros grant was attributed by the EU to the ShikiFactory100 project, an international effort coordinated by biotech SME SilicoLife, in cooperation with some of the most relevant players in Europe, covering leading research institutions, SMEs and a large industrial company.

Resultados del proyecto Mytitox

July 2, 2018 · Made in GalChimia, R&D

During the project, the synthesis of a COF (Covalent Organic Framework), capable of being used to capture toxins in the marine environment to predict toxic episodes, has been scaled.

Resultados del proyecto NEOGALFARM

July 2, 2018 · Made in GalChimia, R&D

Ya están publicados los resultados del Proyecto NEOGALFARM, centrado en la búsqueda de nuevos fármacos para el tratamiento contra el cáncer mediante el desarrollo de terapias dirigidas a diferentes dianas terapéuticas y de tratamientos combinados. ¡Consúltalos aquí!